Particle.news
Download on the App Store
9 ARTICLES
·
4h ago

Ebola Outbreak in DRC Outpaces Response as Virus Reaches Sixth Province

Delayed detection, saturated treatment centres and regional surveillance gaps raise the risk that hidden transmission will spread further.

Passengers who disembarked from a boat intercepted by health authorities wait to be tested following the death of a passenger suspected of having Ebola, in Kinshasa, Democratic Republic of the Congo, August 6, 2026. Authorities said the passenger had disembarked earlier in the city. REUTERS/Benoit Nyemba/File Photo
Gédéon Banga Ngbape, right, an Ebola surveillance officer, arrives at his office in Nizi, Ituri province, eastern Congo, Friday, Aug. 14, 2026. (AP Photo/Dieudonne Dirole)
Members of the Civil Protection team, which works to help mitigate the spread of the Ebola virus, wearing personal protective equipment (PPE), disinfect after handling the body of an unidentified man, who according to his family, died of Ebola, in Bunia, Ituri province, Democratic Republic of Congo, July 10, 2026. REUTERS/Gradel Muyisa Mumbere/File Photo
The outbreak is killing people three times as fast as that of 2015, which was the worst in history (Photo: Dieudonne Dirole/AP)

Overview

  • The Democratic Republic of Congo reported roughly 4,449 confirmed cases and 2,061 deaths in mid‑August, with most infections concentrated in Ituri and a newly confirmed death in Bas‑Uele marking spread to a sixth province.
  • WHO says transmission is occurring faster than authorities can find and isolate cases, with many deaths happening outside health facilities and several treatment and transit centres now saturated.
  • National contact tracing has improved to over 85 percent overall, but sharp regional shortfalls remain and Haut‑Uélé is reporting about a 58 percent tracing rate, leaving gaps that let chains of infection persist.
  • Response teams face growing operational problems, including insecurity, community mistrust, unpaid frontline workers and funding shortfalls, which are delaying safe burials, testing and patient referral.
  • There is no approved vaccine or strain‑specific treatment for the Bundibugyo strain, though early human trials of an mRNA vaccine (mRNA‑1469) have begun in Canada and therapeutic trials have been fast‑tracked, with results expected only after months of study.